Health ❯ Healthcare ❯ Clinical Trials

Patient Care

Personalized Medicine Innovative Treatments Treatment Protocols Treatment Efficacy Precision Medicine Oncology Treatment Strategies Cancer Treatment Treatment Outcomes Medication Efficacy

3 ARTICLES

2mo ago

Researchers Propose Redefining Functional High‑Risk Myeloma as Progression Within 36 Months

The change would shift who is prioritized for early T‑cell redirecting treatments and dedicated clinical trials because their survival after relapse remains about two years or less.

8 ARTICLES

3mo ago

ARPA-H Sets 18-Month Deadline for Human Trials of Knee Osteoarthritis Regeneration Therapies

7 ARTICLES

5mo ago

Donor Skin Patch Shows Early Promise as ‘Window’ on Lung Transplant Rejection

6 ARTICLES

5mo ago

Metformin Triggers Exercise-Linked Signal in Prostate Cancer Patients

6 ARTICLES

6mo ago

Blood Test Detects Glioblastoma With Over 90% Accuracy as Multi‑Site Trial Begins

6 ARTICLES

9mo ago

Slow Tapering With Therapy Matches Staying on Antidepressants, Major Review Finds

8 ARTICLES

9mo ago

New HIV Remission Case and Immunotherapy Trial Signal Immune-Based Paths Off ART

3 ARTICLES

10mo ago

Early Cancer Gene Panel Testing Linked to Longer Survival in Kyoto Study

8 ARTICLES

10mo ago

Mayo Clinic Model Estimates 10-Year and Lifetime Risk of Cognitive Decline

3 ARTICLES

10mo ago

St. Jude Releases Medulloblastoma Risk Model and MB‑Meta Portal to Enable Treatment De‑Escalation

8 ARTICLES

11mo ago

UK Launches National Trial of Breath Test to Spot Pancreatic Cancer Early

3 ARTICLES

11mo ago

Amivantamab ‘Smart Jab’ Shows 76% Disease Control in Advanced Head and Neck Cancer

6 ARTICLES

last yr.

MRI Measure of Brain Iron Predicts Future Cognitive Decline, Radiology Study Finds

4 ARTICLES

last yr.

Nature Study Decodes Cancer’s Epigenetic ‘Black Box’ With EVOFLUx

4 ARTICLES

last yr.

ESC Trials Back Shorter Antiplatelet Therapy for Selected MI Patients

5 ARTICLES

last yr.

Alzheimer Drug Leqembi Launches in Germany and Austria on September 1 Under Strict Conditions

4 ARTICLES

last yr.

Patient Care

Researchers Propose Redefining Functional High‑Risk Myeloma as Progression Within 36 Months

Gene Test Lets Many Over-40 Breast Cancer Patients Skip Chemotherapy

MutationProjector AI Predicts Cancer Therapy Response from Tumor Mutations

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

ARPA-H Sets 18-Month Deadline for Human Trials of Knee Osteoarthritis Regeneration Therapies

Donor Skin Patch Shows Early Promise as ‘Window’ on Lung Transplant Rejection

Metformin Triggers Exercise-Linked Signal in Prostate Cancer Patients

Blood Test Detects Glioblastoma With Over 90% Accuracy as Multi‑Site Trial Begins

Slow Tapering With Therapy Matches Staying on Antidepressants, Major Review Finds

New HIV Remission Case and Immunotherapy Trial Signal Immune-Based Paths Off ART

Never miss stories about

Patient Care

Early Cancer Gene Panel Testing Linked to Longer Survival in Kyoto Study

Mayo Clinic Model Estimates 10-Year and Lifetime Risk of Cognitive Decline

St. Jude Releases Medulloblastoma Risk Model and MB‑Meta Portal to Enable Treatment De‑Escalation

UK Launches National Trial of Breath Test to Spot Pancreatic Cancer Early

Amivantamab ‘Smart Jab’ Shows 76% Disease Control in Advanced Head and Neck Cancer

MRI Measure of Brain Iron Predicts Future Cognitive Decline, Radiology Study Finds

Nature Study Decodes Cancer’s Epigenetic ‘Black Box’ With EVOFLUx

ESC Trials Back Shorter Antiplatelet Therapy for Selected MI Patients

Alzheimer Drug Leqembi Launches in Germany and Austria on September 1 Under Strict Conditions

NF1-Low ER+ Breast Cancers Identified as Likely Responders to CDK4/6 Inhibitors

Never miss stories about

Patient Care